Cargando…

DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor Microenvironment Remodeling in Endometrial Carcinoma

BACKGROUND AND AIM: Deleted in liver cancer 1 (DLC1) is confirmed as a metastasis suppressor gene in endometrial carcinoma (EC). However, its functional mechanisms remain unclear. This study aimed to explore the relationship between DLC1 expression and EC. METHODS: The Cancer Genome Atlas database w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yalan, Zheng, Li-e, Chen, Shumin, Lv, Chengyu, Huang, Yuxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874285/ https://www.ncbi.nlm.nih.gov/pubmed/35223504 http://dx.doi.org/10.3389/fonc.2022.823018

Ejemplares similares

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
por: Xu, Lin, et al.
Publicado: (2021)

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
por: Zhang, Bin, et al.
Publicado: (2021)

Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment
por: Zhao, Yan, et al.
Publicado: (2023)

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis
por: Liu, Yu, et al.
Publicado: (2020)

CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022)

The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
por: Gkretsi, Vasiliki, et al.
Publicado: (2015)

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma
por: Sun, Xu, et al.
Publicado: (2023)

The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma
por: Gu, Chunyan, et al.
Publicado: (2022)

Features of the immunosuppressive tumor microenvironment in endometrial cancer based on molecular subtype
por: Zhang, Chong, et al.
Publicado: (2023)

Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment
por: Cui, Yiyao, et al.
Publicado: (2021)

Machine learning-based neddylation landscape indicates different prognosis and immune microenvironment in endometrial cancer
por: Li, Yi, et al.
Publicado: (2023)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment
por: Chen, Ji, et al.
Publicado: (2022)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
por: Zhu, Jingjuan, et al.
Publicado: (2023)

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas
por: Li, Shuyu, et al.
Publicado: (2022)

Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression
por: Arora, Leena, et al.
Publicado: (2021)

A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancer
por: Wang, Jingshuai, et al.
Publicado: (2022)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
por: Wei, Sitian, et al.
Publicado: (2022)

Anti-Tumor Role of CAMK2B in Remodeling the Stromal Microenvironment and Inhibiting Proliferation in Papillary Renal Cell Carcinoma
por: Jia, Qingan, et al.
Publicado: (2022)

Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Meng, Xiaoyan, et al.
Publicado: (2022)

Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment
por: Wang, Haiqiang, et al.
Publicado: (2022)

DLC1 inhibits colon adenocarcinoma cell migration by promoting secretion of the neurotrophic factor MANF
por: Chu, Yi-Min, et al.
Publicado: (2022)

The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer
por: Sun, Yihan, et al.
Publicado: (2023)

Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation
por: Yuan, Yi, et al.
Publicado: (2021)

Effect of pulsed field ablation on solid tumor cells and microenvironment
por: Wang, Yujue, et al.
Publicado: (2022)

Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhao, Shuai, et al.
Publicado: (2021)

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2021)

Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment
por: Qiu, Wenli, et al.
Publicado: (2022)

Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases
por: La Spina, Enrico, et al.
Publicado: (2023)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis
por: Du, YiHeng, et al.
Publicado: (2021)

m(6)A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma
por: Chen, Lianze, et al.
Publicado: (2021)

Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling
por: Zhao, Liang, et al.
Publicado: (2021)

Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma
por: Chen, Junfeng, et al.
Publicado: (2022)

A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment
por: Liu, Xu, et al.
Publicado: (2022)

Corrigendum: The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis
por: Du, YiHeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6525vrigso398552ts9mlhanlp